Antimicrobial stewardship program in COVID-19 era: Ruin of the reign? | Zendy

Arash Eatemadi | Zendy; Sirous Golchinheydari | Zendy; Mohammed Al Reesi | Zendy; Majid Al Maqbali | Zendy; Talib Al Maqbali | Zendy; Aiman Al Wahaibi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antimicrobial stewardship program in COVID-19 era: Ruin of the reign?

Author(s) -

Arash Eatemadi,

Sirous Golchinheydari,

Mohammed Al Reesi,

Majid Al Maqbali,

Talib Al Maqbali,

Aiman Al Wahaibi

Publication year - 2021

Publication title -

journal of biomedical and pharmaceutical research

Language(s) - English

Resource type - Journals

eISSN - 2589-8752

pISSN - 2279-0594

DOI - 10.32553/jbpr.v9i6.822

Subject(s) - covid-19 , stewardship (theology) , antimicrobial stewardship , antibiotic stewardship , antibiotics , medical prescription , reign , medicine , pandemic , intensive care medicine , disease , infectious disease (medical specialty) , virology , political science , antibiotic resistance , microbiology and biotechnology , nursing , biology , outbreak , politics , law

COVID-19 is the most important matter in the medical field worldwide in 2020. Although COVID-19 is a viral disease, the threshold to antibiotic prescription for COVID-19 patients is low, partly because of WHO recommendations and previous experiences from influenza, despite the lack of strong evidence of co-infection or superimposed bacterial infection in COVID-19 patients. Antibiotic stewardship program (ASP) could play an important role in this period, otherwise, we will face a crisis of superbugs in the early future. Keywords: COVID-19, Antibiotic stewardship program (ASP), Superbugs

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research